Skip to content

decrease hyperlipidemia with amaranthus and D- reglis

Investigating the effects of Amaranthus hybridus leaves extract and Glycyrrhiza glabra root extract on decrease blood lipids in hyperlipidemic subjects

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240624062235N1
Enrollment
74
Registered
2024-07-23
Start date
2024-07-03
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with high blood lipids. Disorder of lipoprotein metabolism, unspecified

Interventions

Intervention 1: Intervention group: This group is given one capsule of Amaranthus hybridus leaves extract and one tablet of Glycyrrhiza glabra root extract daily. The total extract of marigold leaves

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with cholesterol levels higher than 200 to 300 mg/dL Patients with triglycerides between 200 and 300 ml/dL Patients with HDL less than 29 mg/dL in men and less than 35 mg/dL in women Patients with LDL between 130 and 190

Exclusion criteria

Exclusion criteria: Presence of serious heart disease, heart attack or stroke, severe kidney or liver disease, uncontrolled diabetes and malignancies in the last six months Presence of pregnancy in women Use of other herbal medicines in addition to prescribed medicines during the study. Use of artificial drugs affecting blood lipids Use of alcohol and drugs

Design outcomes

Primary

MeasureTime frame
Blood lipid levels. Timepoint: One day before the intervention and one day after the intervention is measured. Method of measurement: By biochemical test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeied Amirhosein Latifi

Arak University of Medical Sciences

seiedalatifi@yahoo.com+98 86 3417 3601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026